Archive
Alternative Therapies

We recently started using RightEye eye-tracking equipment which can help our patients who are suffering from visual difficulties due to migraines, concussion, or traumatic brain injury (TBI). Many brain disorders can impair the control of eye movements. This can lead to incorrect information being passed from the eyes to the brain, which can worsen brain dysfunction. Eye strain can also contribute to migraines and post-concussion headaches.

The RightEye computer has a built-in infrared eye-tracking device that can accurately diagnose different abnormal eye movements. It tests smooth pursuit, vertical and horizontal saccades, reading, reaction time, and other functions. A recent study, Vertical smooth pursuit as a diagnostic marker of traumatic brain injury showed a correlation between moderate and severe TBI and abnormal eye movements.

Eye movement problems after TBI were also reported in a study published in the Journal of Neurotrauma , Eye Tracking Detects Disconjugate Eye Movements Associated with Structural Traumatic Brain Injury and Concussion.

A study in the journal Brain showed that eye movement difficulties were still present 3 to 5 months after the concussion and that they were not affected by the presence of depression or degree of intellectual ability. Compared with neuropsychological tests, eye movements were more likely to be markedly impaired in patients with many postconcussion symptoms.

While there are no studies showing that migraines improve with eye exercises, there is some evidence that symptoms of concussion which can include migraine headaches, do improve. A review of several published studies of vision therapy for post-concussion symptoms found it “promising”.

Why would we offer this eye movement therapy in the absence of definitive proof of its efficacy? Mostly because there are limited options for the treatment of concussion and migraines with prominent visual symptoms. We also consulted experts at SUNY College of Optometry in NYC and they were very positive about the potential benefits of this therapy.

The testing process takes about 10 minutes. If problems are found, patients are prescribed specific eye exercises that are done daily by logging into RightEye company’s portal.

Read More

Tonight at 6 PM (EST), Dr. Mauskop will speak at the Weekly Wellness with the American Migraine Foundation. He will discuss the role of exercise in the management of migraine headaches and the results of scientific clinical trials, as well as practical information about various types of exercise such as aerobic (cardiovascular), isometric, high-intensity interval testing, and the Feldenkrais method. He will also provide advice on how to avoid exercise-induced and exertional headaches. You can log in to see this event and ask questions here – https://www.facebook.com/events/730534437480323/

Read More

Nerivio is a smartphone-controlled wireless device that provides electrical stimulation of the type that is similar to TENS units widely used in physical therapy for musculoskeletal disorders. It was approved by the FDA last year for the treatment of acute migraines.

Nerivio was proven to be effective in a double-blind, sham-controlled study of 252 adults with migraine headaches. It was applied for 40 minutes on the upper arm and the strength of the current is gradually increased to a strong but non-painful intensity level. Active stimulation was more effective than sham stimulation in achieving pain relief (67% vs 39%), pain-free state (37% vs 18%), and relief of the most bothersome symptom such as nausea sensitivity to light or noise (46% vs 22%) at 2 hours post-treatment. The pain relief and pain-free superiority of the active treatment was sustained 48 hours post-treatment. The device was very well tolerated with only a few patients reporting local irritation.

This device is controlled by a smartphone which allows the manufacturer to collect data about its use (with patients’ permission and without identifying individual patients). After 6 months of my prescribing this device to a couple of hundred of patients, 62% of my patients reported having pain relief after 2 hours and 24% reported to be pain free after 2 hours. These numbers are comparable to the results seen with migraine drugs such as triptans (sumatriptan or Imitrex and other) as well as the new class of abortive migraine drugs, gepants (ubrogepant or Ubrelvy and rimegepant or Nurtec ODT). One big advantage of Nerivio is that it is not ingested and is much less likely to cause any side effects.

Theranica, the manufacturer of Nerivio is working to expand the indications for the device by conducting trials in adolescents and patients with chronic migraines.

Nerivio is not covered by most insurance companies and costs $99 for each disposable device which provides 12 treatments. It is available only by prescription. If you have difficulty finding a headache specialist, since the start of the pandemic we have begun to offer telemedicine visits using HIPAA-compliant platform. You can call our front desk (212-794-3550) to schedule an appointment.

Read More

Vitamin C or ascorbic acid (AA) was discovered by Albert von Szent-Györgyi for which he received the 1937 Nobel Prize in Medicine. Linus Poling, one of only 4 people to win the Nobel prize twice, devoted many years of his life to researching AA. A wealth of information on AA is available on Oregon State University’s Linus Pauling Institute website.

Many studies have shown that AA is important in collagen formation. It is also important for the proliferation of stem cells. A study of 1210 hospitalized patients showed that intravenous infusion of AA in doses of 3–10 grams/day reduced the mortality of critically ill patients. AA also plays a vital role in the functioning of the immune system as well as inflammation.

This post was prompted not only by thoughts of how to boost your immunity and increase your resistance to viral infections but also by a recent paper with a catchy title, Dietary ascorbic acid restriction in GNL/SMP30-knockout mice unveils the role of ascorbic acid in regulation of somatic and visceral pain sensitivity. The authors conclude “our data unveil the critical role of ascorbic acid in regulating somatic and visceral pain sensitivity and support accumulating clinical evidence for the usefulness of ascorbic acid in pain management.”

Another example of a basic science study of the role of AA in pain modulation is Evidence for the involvement of glutamatergic system in the antinociceptive effect of ascorbic acid.

And what about migraines? Surprisingly, nobody has done any studies of AA for the treatment of migraines. There is only one case report published in The New England Journal of Medicine describing a 32-year-old man who controlled his migraine headaches with a daily dose of 6 grams of ascorbic acid for six years. He participated in a double-blind study in which he was given either AA or placebo. At the end of 15 days, he correctly identified all days he had received vitamin C and all days he had received a placebo.

How much should you take? The Linus Pauling Institute suggests 400 mg a day, although many popular vitamin C supplements contain 1,000 mg. Taking 1,000 mg is safe, although any amount of AA can cause heartburn or upset stomach because vitamin C is an acid.

Read More

Vitamin D level testing is no longer covered by many insurers and many doctors, NY Times, and other media consider taking vitamin D supplements of unproven benefit. I’ve written 10 blog posts over the past 12 years on vitamin D. These posts describe highly scientific studies of the role of vitamin D deficiency on the development of delirium in hospitalized patients, multiple sclerosis, major diseases and dying, and of course migraines.

This morning, Dr. Leo Galland during his TV appearance mentioned the importance of supplements that can boost the immune system and reduce our susceptibility to viral diseases. He mentioned vitamin D and curcumin. Dr. Galland is a highly respected physician who often helps patients with problems that are difficult to diagnose and treat. I’ve reviewed one of his excellent books The Allergy Solution in a previous post.

What prompted another post on vitamin D besides Dr. Galland’s TV appearance, was a 593-patient Mayo Clinic study which reported increased severity of fibromyalgia in patients with vitamin D deficiency. Of these 593 patients, 122 or 21% had vitamin D deficiency. Patients with lower vitamin D levels also reported higher rates of anxiety and depression and were more likely to be overweight.

If you do get your vitamin D level tested, check what the actual result is. The normal range in most laboratories is from 30 to 100. However, if you are at the bottom of the normal range, you may be deficient and be more predisposed to a variety of medical conditions. Keep your level at least in the middle of the range.

Read More

Sarah Hiner, President of BottomLineInc interviews me for The Bottom Line Advocator podcast – 7 New Treatments for Migraines Just Released — with Alexander Mauskop, MD

Read More
Acupuncture has been subjected to a very large number of clinical trials for a variety of conditions, including migraine headaches. Dr. Zhang, a neurologist at Stanford and two of his colleagues have published a review of trials that compared acupuncture with standard pharmacological migraine therapy.The review included only scientifically rigorous trials that compared the efficacy of acupuncture with a standard migraine preventive medication in adult patients with a diagnosis of chronic or episodic migraine with or without aura.

Out of the 706 published reports, 7 clinical trials, with a total of 1430 participants were of high quality. Modes of acupuncture and pharmacological treatments varied from trial to trial, which made it difficult to make any sweeping conclusions. However, several of the studies showed acupuncture to be more effective than the standard pharmacological treatments for migraine prevention.

Even if acupuncture is only as effective as drugs, its safety makes it a superior choice. The major drawbacks of acupuncture are that it is time-consuming and relatively expensive when compared to generic prescription drugs. These are the reasons why I rarely perform acupuncture on my patients. If someone is interested in acupuncture, I do encourage them to try it and refer them to well-trained lower-cost non-physician providers.

 

Read More

Light sensitivity is a common feature of migraine headaches and during an attack most people prefer being in the dark. According to a Harvard professor, Dr. Rami Burstein, exposure to pure green light may be better than being in complete darkness.

Dr. Burstein is one of the world’s most productive and creative headache researchers. His research has been published in such leading medical journals as Brain, Nature, Pain, Neurology, Journal of Neuroscience, and many other. This is to say that his research is of high quality and can be trusted.

I’ve known Rami for over 20 years and he never ceases to surprise with a fresh look at old phenomena that have lead him to many breakthrough discoveries. While studying light sensitivity, he decided to look at the effect of different parts of the visible light spectrum on the brain of experimental animals as well as migraine sufferers.  According to his research published in Brain, white light as well as other colors of the spectrum worsen pain perception, but green light reduces pain. Blue light produces the strongest pain response and this is why some of my patients find relief from wearing orange-colored lenses that block the blue part of the spectrum.

Another paper by Burstein and his colleagues published in the Proceedings of the National Academy of Sciences suggests that exposure green light also has a positive effect on mood and autonomic nervous system functions.

Because of these findings Dr. Burstein developed a lamp that produces pure green color. A regular green-tinted bulb will not work because it does not emit a pure green light. Admixture of other colors negates the beneficial effect of the purely green light. He told me that the original prototype of the lamp cost $50,000, but eventually he and his business partners were able to reduce the price to a couple of hundred dollars. Now, you may think that he is out to make some money on his research, but that is not the case. Being a full professor at Harvard means that the university keeps the profits.

The lamp became available only a month ago and you can buy it at AllayLamp.com.  Keep in mind that for green light to work, you have to turn off all other lights and computer screens and close the shades. It may take 1-2 hours to make your pain, throbbing, and other symptoms to subside. A patient I recently saw loved the idea of this lamp because whenever she gets a migraine in the summer she finds relief by sitting in her dense green garden.

Read More

Vitamin B12 (cyanocobalamin) deficiency has been long suspected to play a role in the development of migraines, but so far it has not been directly linked to migraines.

A new study published in the latest issue of Headache compared vitamin B12 status in 70 migraine sufferers with 70 healthy people with similar demographics. Serum levels of vitamin B12 were found to be significantly lower in migraine patients than in healthy subjects. Vitamin B12 levels are notoriously inaccurate, so the authors confirmed this finding by testing for a more sensitive indicator of deficiency, methylmalonic acid (MMA), which goes up as the vitamin B12 levels go down. Patients with the B12 levels in the highest quartile had 80% lower chance of having migraines compared to those with levels in the bottom quartile. Patients in the highest quartile of MMA had more than 5 times increased risk of having migraines.

In a study migraine sufferers with elevated homocysteine levels, which is another indicator of deficiency of vitamin B12 and other B vitamins, were given vitamins B12, folic acid and vitamin B6. Their homocysteine levels dropped and migraine-related disability improved. Elevated homocysteine level is suspected to be responsible for the increased risk of strokes in patients with migraines with aura, although that is still unproven.

This latest study only shows correlation, but it does not prove that taking vitamin B12 and increasing your serum level will relieve migraines. Nevertheless, it makes sense to have your level at least in the middle of normal range since vitamin B12 is important for many brain functions. For example, multiple sclerosis patients with low B12 levels have higher disability and vitamin B12 deficiency may predispose to Alzheimer’s disease.

I’ve written in the past that long-term intake of heartburn drugs often leads to vitamin B12 deficiency. You may want to read an article in the Wall Street Journal published earlier this year, Vitamin B-12 Deficiency: The Serious Health Problem That’s Easy To Miss.

Read More

Cove, a telemedicine startup provides medical care to people suffering from migraines. There are 40 million migraine sufferers in the US, only half of whom seek medical care. The other half may have mild migraines, not have access to medical care, or are under the impression that nothing can be done about their headaches. Only half of the half that go to a doctor receive a correct diagnosis of migraine. The other half, or about 10 million, are misdiagnosed as sinus, tension, or stress headaches and never receive effective treatment.

Withcove.com is website where migraine sufferers can have a neurologist evaluate their symptoms and provide an accurate diagnosis and prescribe individualized treatment. It may seem that not seeing a doctor in person would be a major obstacle, but it is not. The patient completes a questionnaire and video is used for neurological examination. The doctor evaluates the information and prescribes migraine drugs, both for the acute treatment of an attack, as well for prevention. You don’t even need to go to a pharmacy – the medicine is shipped to you. Cove also offers a variety of supplements, such as magnesium and CoQ10, which can be more effective and safer for the prevention of migraines than drugs.

My colleague at the NY Headache Center, Dr. Sara Crystal and I are helping Cove with the design of proper evaluation tools, treatment algorithms, and other aspects of care.

In addition to providing direct care, Cove is conducting some research as well. In a survey of nearly 1,000 people, a combination of Cove customers and other migraine sufferers, Cove looked at the impact of migraine on careers, to identify coping strategies, and to provide tools that make it easier to get ahead. You can read the full report, “When Migraine Gets In the Way of Careers”.

Here is a sample of the survey findings:
47% of migraine sufferers who are employed feel that migraines have held them back from advancing in their career.
30% of employed migraine sufferers said that they’ve needed to quit a job, turn down responsibilities at their current job, and/or not accept a new job because of their migraines.
38% of employed migraine sufferers have missed 5+ days of work in the past 12 months due to their migraines.

These are shocking numbers, but in line with the data known to headache specialists. Migraine is ranked globally as the seventh most disabling disease among all diseases and is the leading cause of disability among all neurological disorders. Unfortunately, research into migraines does not receive appropriate attention from the National Institutes of Health and other funding sources.

Read More

A large study confirms previous reports of the beneficial effect of onabotulinumtoxinA (Botox) injections on depression as well as anxiety. In my two previous blog posts from 2011 and 2014 I mentioned reports of cosmetic Botox injections relieving depression but those involved a relatively small number of patients.

A study published in the Journal of Neurology, Neurosurgery, & Psychiatry under the title Effects of onabotulinumtoxinA treatment for chronic migraine on common comorbidities including depression and anxiety ,described the COMPEL trial (Chronic Migraine OnabotulinumtoxinA Prolonged Efficacy Open-Label). It was a multicenter, open-label, prospective study assessing the long-term safety and efficacy of 155 units of onabotulinumtoxinA (Botox) over nine treatments (108 weeks) in adults with chronic migraines.

OnabotulinumtoxinA treatment was associated with sustained reduction in headache days and depression and anxiety scores in the 715 patients over 108 weeks. The anxiety and depression scores were significantly reduced at all time points in patients with clinically significant symptoms of depression and/or anxiety at baseline. By week 108, 78% and 82% had clinically meaningful improvement in depression and anxiety symptoms, respectively. Sleep quality and symptoms of fatigue also improved.

In an earlier poster presentation of this data at a scientific conference the authors reported that the improvement in anxiety and depression was seen even in patients whose migraines did not improve with Botox. Even if that were true, we need a separate large study of Botox for anxiety and depression. The one study that treated patients with major depression in a double-blind, placebo-controlled trial involved only 74 patients.

In my practice, I’ve treated one young woman with severe bipolar disorder which did not respond to multiple drugs and who had a dramatic response to Botox. She has been receiving injections for over two years with sustained improvement. Another young man with depression had a very significant response as well, but has had only one treatment so far. I came to treat them accidentally – both were adopted children of my migraine patient who read about this possible effect of Botox and asked me to try it.

Read More

Medication overuse headache (MOH) is not proven to occur from the frequent intake of triptans (Imitrex, or sumatriptan and other) or NSAIDs (ibuprofen, naproxen, and other). However, there is good evidence that caffeine (and opioid analgesics) which can help relieve an occasional migraine, can definitely make them worse if taken frequently. Caffeine withdrawal is a proven trigger of headaches, including migraines.

While we know that caffeine withdrawal causes headaches, a study just published by Harvard researchers in The American Journal of Medicine addressed an unexamined question – does drinking coffee directly triggers a migraine?

This was a rigorous prospective study of 98 adults with episodic migraine who completed electronic diaries every morning and evening for a minimum of 6 weeks. 86 participants were women and 12 were men, with mean age of 35 and the average age of onset of headaches of 16. Every day, participants reported caffeinated beverage intake, other lifestyle factors, and the timing and characteristics of each migraine headache. The researchers compared incidence of migraines on days with caffeinated beverage intake to the incidence of migraines by the same individual on days with no intake. In total, the participants reported 825 migraines during 4467 days of observation.

There was a significant association between the number of caffeinated beverages and the odds of migraine headache occurrence on that day. This association was stronger in those who normally drank 1-2 cups of coffee daily – they were more likely to get a migraine on days when they drank 3 or more cups.

Even after accounting for daily alcohol intake, stress, sleep, activity, and menstrual bleeding, 1-2 servings of caffeinated beverages were not associated with headaches on that day, but 3 or more servings were associated with higher odds of headaches, even after accounting for daily alcohol intake, stress, sleep, activity, and menstrual bleeding. The researchers also considered the possibility of reverse causation, meaning that people might have drank coffee to treat a headache, but this was also not the case.

My advice to migraine sufferers is to drink not more than 1 cup of coffee a day, and I don’t mean a Venti (24 oz) cup from Starbucks, but an 8-ounce cup of regular strength coffee. During a migraine attack having an extra cup along with your usual medication may provide additional relief.

Read More